Cyclarity Therapeutics, Inc.

This early-stage study aims to test the safety of an experimental drug called UDP-003 in healthy volunteers and people with a history of heart attacks or chest pain. Researchers want to see how the body processes the drug and get a first look at whether it might reduce dangerous …